Yizhen Fu

14PUBLICATIONS
23CO-AUTHORS
HaematologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursRadiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 01, 2026
HAIC Combined with Lenvatinib and Pembrolizumab for Unresectable Hepatocellular Carcinoma: A Retrospective Study.

|Aug 11, 2025
Social Support, Quality of Life, and Financial Toxicity Among Patients with Hepatocellular Carcinoma.

Shuyue Liu, Yawen Xie, Tiantian Li

|Feb 04, 2025
Transarterial Chemoembolization with Radiofrequency Ablation versus Surgical Resection for Small Late-Recurrence Hepatocellular Carcinoma.

Yao-Jun Zhang, Jinbin Chen, Zhongguo Zhou

|Jan 21, 2025
Comparing PD-L1 and PD-1 inhibitors plus bevacizumab combined with hepatic arterial interventional therapies in unresetable hepatocellular carcinoma: A single-center, real-world study.

Minrui He, Wa Xie, Ze Yuan

|Dec 18, 2024
Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Recurrent Small Hepatocellular Carcinoma: A Randomized, Open-Label, Controlled Trial.

Mian Xi, Zhoutian Yang, Li Hu

|Oct 31, 2024
The Efficacy and Safety of Bevacizumab Plus Anti-PD-1/PD-L1 Inhibitors in Combination with Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular Carcinoma.

Xiang Tang, Jinbin Chen, Wei Peng

Pageof 3

Frequent Collaborators

10 joint publications

Yaojun Zhang

7 joint publications

Zili Hu

6 joint publications

Yangxun Pan

6 joint publications

Jinbin Chen